ATE382055T1 - Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren - Google Patents
Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäurenInfo
- Publication number
- ATE382055T1 ATE382055T1 AT01920759T AT01920759T ATE382055T1 AT E382055 T1 ATE382055 T1 AT E382055T1 AT 01920759 T AT01920759 T AT 01920759T AT 01920759 T AT01920759 T AT 01920759T AT E382055 T1 ATE382055 T1 AT E382055T1
- Authority
- AT
- Austria
- Prior art keywords
- wnt
- nucleic acids
- acids encoding
- related polypeptides
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19125800P | 2000-03-22 | 2000-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382055T1 true ATE382055T1 (de) | 2008-01-15 |
Family
ID=38885296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01920759T ATE382055T1 (de) | 2000-03-22 | 2001-03-22 | Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20020098540A1 (de) |
| EP (1) | EP1265914B1 (de) |
| JP (1) | JP2003527849A (de) |
| AT (1) | ATE382055T1 (de) |
| AU (2) | AU4778101A (de) |
| CA (1) | CA2404216A1 (de) |
| DE (1) | DE60132075T2 (de) |
| DK (1) | DK1265914T3 (de) |
| ES (1) | ES2298226T3 (de) |
| PT (1) | PT1265914E (de) |
| WO (1) | WO2001070775A2 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0114644D0 (en) * | 2001-06-15 | 2001-08-08 | Oxford Glycosciences Uk Ltd | Protein |
| EP1500665B1 (de) | 2002-04-15 | 2011-06-15 | Chugai Seiyaku Kabushiki Kaisha | VERFAHREN ZUR HERSTELLUNG VON scDb-BIBLIOTHEKEN |
| US8337841B2 (en) | 2003-01-21 | 2012-12-25 | Chugai Seiyaku Kabushiki Kaisha | Methods of screening for antibody light chains |
| JP4794301B2 (ja) | 2003-06-11 | 2011-10-19 | 中外製薬株式会社 | 抗体の製造方法 |
| EP1693386A4 (de) * | 2003-11-04 | 2008-12-31 | Chugai Pharmaceutical Co Ltd | Verfahren zur herstellung von antikörpern |
| US20050251054A1 (en) * | 2004-05-10 | 2005-11-10 | Medpond, Llc | Method and apparatus for measurement of autonomic nervous system function |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| JP5057967B2 (ja) | 2005-03-31 | 2012-10-24 | 中外製薬株式会社 | sc(Fv)2構造異性体 |
| JP5085322B2 (ja) | 2005-06-10 | 2012-11-28 | 中外製薬株式会社 | sc(Fv)2を含有する医薬組成物 |
| CN101237890A (zh) | 2005-06-10 | 2008-08-06 | 中外制药株式会社 | 含有葡甲胺的蛋白质制剂的稳定剂及其利用 |
| JP5144499B2 (ja) | 2006-03-31 | 2013-02-13 | 中外製薬株式会社 | 二重特異性抗体を精製するための抗体改変方法 |
| CA2730068A1 (en) | 2008-07-07 | 2010-01-14 | Oxford Nanopore Technologies Limited | Base-detecting pore |
| US20110229877A1 (en) | 2008-07-07 | 2011-09-22 | Oxford Nanopore Technologies Limited | Enzyme-pore constructs |
| GB0820927D0 (en) | 2008-11-14 | 2008-12-24 | Isis Innovation | Method |
| CN102482330A (zh) * | 2009-01-30 | 2012-05-30 | 牛津纳米孔技术有限公司 | 酶突变体 |
| EP2391732B1 (de) | 2009-01-30 | 2015-05-27 | Oxford Nanopore Technologies Limited | Verfahren die adaptoren zur nukleinsaure constructen für transmembrane sequenzierung benutzen |
| GB0905140D0 (en) | 2009-03-25 | 2009-05-06 | Isis Innovation | Method |
| BR112013020411B1 (pt) | 2011-02-11 | 2021-09-08 | Oxford Nanopore Technologies Limited | Monômero de msp mutante, construto, polinucleotídeo, poro, kit e aparelho para caracterizar uma sequência de ácido nucleico alvo, e, método para caracterizar uma sequência de ácido nucleico alvo |
| KR20140050067A (ko) | 2011-07-25 | 2014-04-28 | 옥스포드 나노포어 테크놀로지즈 리미티드 | 막횡단 포어를 사용한 이중 가닥 폴리뉴클레오티드 서열분석을 위한 헤어핀 루프 방법 |
| WO2013153359A1 (en) | 2012-04-10 | 2013-10-17 | Oxford Nanopore Technologies Limited | Mutant lysenin pores |
| US11155860B2 (en) | 2012-07-19 | 2021-10-26 | Oxford Nanopore Technologies Ltd. | SSB method |
| GB201314695D0 (en) | 2013-08-16 | 2013-10-02 | Oxford Nanopore Tech Ltd | Method |
| CA2901545C (en) | 2013-03-08 | 2019-10-08 | Oxford Nanopore Technologies Limited | Use of spacer elements in a nucleic acid to control movement of a helicase |
| GB201313477D0 (en) | 2013-07-29 | 2013-09-11 | Univ Leuven Kath | Nanopore biosensors for detection of proteins and nucleic acids |
| CA2925256C (en) | 2013-09-27 | 2023-08-15 | Chugai Seiyaku Kabushiki Kaisha | Method for producing polypeptide heteromultimer |
| GB201403096D0 (en) | 2014-02-21 | 2014-04-09 | Oxford Nanopore Tech Ltd | Sample preparation method |
| US10443097B2 (en) | 2014-05-02 | 2019-10-15 | Oxford Nanopore Technologies Ltd. | Method of improving the movement of a target polynucleotide with respect to a transmembrane pore |
| CN119899249A (zh) | 2014-09-01 | 2025-04-29 | 弗拉芒区生物技术研究所 | 突变csgg孔 |
| US10266885B2 (en) | 2014-10-07 | 2019-04-23 | Oxford Nanopore Technologies Ltd. | Mutant pores |
| GB201418159D0 (en) | 2014-10-14 | 2014-11-26 | Oxford Nanopore Tech Ltd | Method |
| SG11201803989WA (en) | 2015-12-28 | 2018-06-28 | Chugai Pharmaceutical Co Ltd | Method for promoting efficiency of purification of fc region-containing polypeptide |
| GB201609220D0 (en) | 2016-05-25 | 2016-07-06 | Oxford Nanopore Tech Ltd | Method |
| GB201807793D0 (en) | 2018-05-14 | 2018-06-27 | Oxford Nanopore Tech Ltd | Method |
| CN114457052B (zh) * | 2021-09-17 | 2024-02-27 | 厦门大学 | 一种抗肿瘤的多肽组合物及其应用 |
-
2001
- 2001-03-22 JP JP2001568976A patent/JP2003527849A/ja active Pending
- 2001-03-22 PT PT01920759T patent/PT1265914E/pt unknown
- 2001-03-22 DE DE60132075T patent/DE60132075T2/de not_active Expired - Lifetime
- 2001-03-22 EP EP01920759A patent/EP1265914B1/de not_active Expired - Lifetime
- 2001-03-22 AU AU4778101A patent/AU4778101A/xx active Pending
- 2001-03-22 US US09/815,248 patent/US20020098540A1/en not_active Abandoned
- 2001-03-22 CA CA002404216A patent/CA2404216A1/en not_active Abandoned
- 2001-03-22 DK DK01920759T patent/DK1265914T3/da active
- 2001-03-22 AT AT01920759T patent/ATE382055T1/de active
- 2001-03-22 ES ES01920759T patent/ES2298226T3/es not_active Expired - Lifetime
- 2001-03-22 AU AU2001247781A patent/AU2001247781C1/en not_active Ceased
- 2001-03-22 WO PCT/US2001/009600 patent/WO2001070775A2/en not_active Ceased
-
2003
- 2003-04-24 US US10/422,335 patent/US20050159373A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/931,835 patent/US20080206252A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2404216A1 (en) | 2001-09-27 |
| US20050159373A1 (en) | 2005-07-21 |
| EP1265914A2 (de) | 2002-12-18 |
| US20020098540A1 (en) | 2002-07-25 |
| DE60132075D1 (de) | 2008-02-07 |
| AU2001247781C1 (en) | 2006-08-17 |
| AU2001247781B2 (en) | 2006-02-02 |
| JP2003527849A (ja) | 2003-09-24 |
| PT1265914E (pt) | 2008-04-08 |
| ES2298226T3 (es) | 2008-05-16 |
| WO2001070775A3 (en) | 2002-01-10 |
| EP1265914B1 (de) | 2007-12-26 |
| US20080206252A1 (en) | 2008-08-28 |
| WO2001070775A2 (en) | 2001-09-27 |
| AU4778101A (en) | 2001-10-03 |
| DK1265914T3 (da) | 2008-03-10 |
| DE60132075T2 (de) | 2009-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60132075D1 (de) | Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren | |
| NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
| DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
| ATE368053T1 (de) | Antimikrobielle peptide | |
| GB9823897D0 (en) | Immunotherapeutic methods and molecules | |
| ATE229977T1 (de) | Peptide mit antiproliferativen eigenschaften | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe | |
| EP1117682A4 (de) | Peptide | |
| ATE356145T1 (de) | Polypeptide zur regenerierung des nervensystems | |
| AU4945001A (en) | Angiogenesis associated proteins, and nucleic acids encoding the same | |
| WO2001098355A3 (en) | Cgi-69 compositions and methods of use | |
| ATE315646T1 (de) | Leukocyten-aktivierender faktor | |
| DE69936513D1 (de) | Menschliche p51-gene und deren genprodukte | |
| DE69831584T2 (de) | Polypeptide mit wasserkanalaktivität und dna sequenzen | |
| DE60037413D1 (de) | Rekombinante adhesin-proteine aus haemophilus influenzae | |
| ATE332373T1 (de) | Menschlisches il-1 epsilon dna und polypeptide | |
| ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| WO2002072765A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| WO2002097036A3 (en) | Compositions and methods for adipose abundant protein | |
| WO2002096355A3 (en) | Compositions and methods for adipose abundant protein | |
| HUP0001462A2 (en) | Human toll-like receptor proteins, related reagents and methods | |
| CO5400145A1 (es) | Proteina asociada con enfermedad | |
| WO2002068648A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof | |
| WO2002061088A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| SE0002738D0 (sv) | Electric actuator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1265914 Country of ref document: EP |